AMP-activated protein kinase: the energy charge hypothesis revisited

被引:647
作者
Hardie, DG [1 ]
Hawley, SA [1 ]
机构
[1] Univ Dundee, Sch Life Sci, Div Mol Physiol, Wellcome Trust Bioctr, Dundee DD1 5EH, Scotland
关键词
D O I
10.1002/bies.10009
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The AMP-activated protein kinase cascade is a sensor of cellular energy charge, and its existence provides strong support for the energy charge hypothesis first proposed by Daniel Atkinson in the 1960s. The system is activated in an ultrasensitive manner by cellular stresses that deplete ATP (and consequently elevate AMP), either by inhibiting ATP production (e.g., hypoxia), or by accelerating ATP consumption (e.g., exercise in muscle). Once activated, it switches on catabolic pathways, both acutely by phosphorylation of metabolic enzymes and chronically by effects on gene expression, and switches off many ATP-consuming processes. Recent work suggests that activation of AMPK is responsible for many of the effects of physical exercise, both the rapid metabolic effects and the adaptations that occur during training. Dominant mutations in regulatory subunit isoforms (gamma2 and gamma3) of AMPK, which appear to increase the basal activity in the absence of AMP, lead to hypertrophy of cardiac and skeletal muscle respectively. (C) 2001 John Wiley & Sons, Inc.
引用
收藏
页码:1112 / 1119
页数:8
相关论文
共 68 条
[1]   Stimulation of AMP-activated protein kinase (AMPK) is associated with enhancement of Glut1-mediated glucose transport [J].
Abbud, W ;
Habinowski, S ;
Zhang, JZ ;
Kendrew, J ;
Elkairi, FS ;
Kemp, BE ;
Witters, LA ;
Ismail-Beigi, F .
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 2000, 380 (02) :347-352
[2]  
Amos AF, 1997, DIABETIC MED, V14, pS7, DOI 10.1002/(SICI)1096-9136(199712)14:5+<S7::AID-DIA522>3.3.CO
[3]  
2-I
[5]   MODULATION OF 3-HYDROXY-3-METHYLGLUTARYL COENZYME A REDUCTASE-ACTIVITY WITH CAMP AND WITH PROTEIN FRACTIONS OF RAT-LIVER CYTOSOL [J].
BEG, ZH ;
ALLMANN, DW ;
GIBSON, DM .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1973, 54 (04) :1362-1369
[6]   Effect of 5-aminoimidazole-4-carboxamide-1-β-D-ribofuranoside infusion on in vivo glucose and lipid metabolism in lean and obese Zucker rats [J].
Bergeron, R ;
Previs, SF ;
Cline, GW ;
Perret, P ;
Russell, RR ;
Young, LH ;
Shulman, GI .
DIABETES, 2001, 50 (05) :1076-1082
[7]   Mutations in the γ2 subunit of AMP-activated protein kinase cause familial hypertrophic cardiomyopathy:: evidence for the central role of energy compromise in disease pathogenesis [J].
Blair, E ;
Redwood, C ;
Ashrafian, H ;
Oliveira, M ;
Broxholme, J ;
Kerr, B ;
Salmon, A ;
Östman-Smith, I ;
Watkins, H .
HUMAN MOLECULAR GENETICS, 2001, 10 (11) :1215-1220
[8]   The AMP-activated protein kinase prevents ceramide synthesis de novo and apoptosis in astrocytes [J].
Blázquez, C ;
Geelen, MJH ;
Velasco, G ;
Guzmán, M .
FEBS LETTERS, 2001, 489 (2-3) :149-153
[9]   Chronic treatment with 5-aminoimidazole-4-carboxamide-1-β-D-ribofuranoside increases insulin-stimulated glucose uptake and GLUT4 translocation in rat skeletal muscles in a fiber type-specific manner [J].
Buhl, ES ;
Jessen, N ;
Schmitz, O ;
Pedersen, SB ;
Pedersen, O ;
Holman, GD ;
Lund, S .
DIABETES, 2001, 50 (01) :12-17
[10]   A COMMON BICYCLIC PROTEIN-KINASE CASCADE INACTIVATES THE REGULATORY ENZYMES OF FATTY-ACID AND CHOLESTEROL-BIOSYNTHESIS [J].
CARLING, D ;
ZAMMIT, VA ;
HARDIE, DG .
FEBS LETTERS, 1987, 223 (02) :217-222